{"entity":{"id":"thomas-herzog","kind":"person","name":"Thomas Herzog","aka":[],"tldr":"Cincinnati gynecologic oncologist who has led the GOG Foundation as President since July 2023.","summary":"Thomas Herzog took office as President of The GOG Foundation, Inc. on 20 July 2023. He is Deputy Director of the University of Cincinnati Cancer Center and the Paul and Carolyn Flory Professor in the Department of Obstetrics and Gynecology. His research focuses on ovarian and other gynecologic cancers and on the design of cooperative-group and industry-partnered clinical trials.","asOf":"2026-09-10","links":[{"label":"Society page","url":"https://www.gog.org/about/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Herzog+TJ%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","gynecologic oncology","ovarian cancer"],"related":[],"cancers":["ovarian","endometrial","cervical"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["gog-foundation"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["international-journal-of-gynecological-cancer"],"dependsOn":[],"notes":[],"role":"President","institutionId":"gog-foundation","specialisms":["Gynecologic oncology","Ovarian cancer","Clinical trials"],"profiles":[{"label":"Society page","url":"https://www.gog.org/about/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Herzog+TJ%5BAuthor%5D"}],"papers":[{"title":"Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study","journal":"Journal of Clinical Oncology","year":2015,"doi":"10.1200/jco.2014.55.9898"},{"title":"An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044)","journal":"Gynecologic Oncology","year":2025,"doi":"10.1016/j.ygyno.2025.03.001"},{"title":"Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners","journal":"International Journal of Gynecological Cancer","year":2026,"doi":"10.1016/j.ijgc.2026.104753"}],"orcid":"0000-0002-4584-8908"},"route":"/people/thomas-herzog/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"company":[{"id":"gog-foundation","kind":"company","name":"GOG Foundation","route":"/companies/gog-foundation/"}],"journal":[{"id":"international-journal-of-gynecological-cancer","kind":"journal","name":"International journal of gynecological cancer","route":"/journals/international-journal-of-gynecological-cancer/"}]}}